Tag: MHRA
Mundipharma empowers global healthcare access with acquisition of Rezafungin rights
The acquisition by Mundipharma aims to intensifying focus on infectious diseases
In a recent announcement, Mundipharma, a leading global pharmaceutical company, has announced its acquisition...
MHRA approves Pfizer’s Velsipity to treat people with ulcerative colitis
Studies showed that 26% of those who received the once-daily tablet achieved clinical remission after 12 weeks of treatment. Â Â
American pharmaceutical giant Pfizer has...
Reclassification of medicines delivers huge benefits for patients, pharmacy and NHS: PAGB
Future reclassifications of appropriate medicines can lead to a 5 per cent reduction in NHS prescribing spend and a potential NHS saving of £1.4...
Valproate National Patient Safety Alert – GPhC tells what pharmacists need to do
Pharmacy teams should be prepared to discuss the current warnings and upcoming measures with their patients
The General Pharmaceutical Council (GPhC) on Thursday sent...
AstraZeneca UK amends ‘incorrect’ expiry dates of flu nasal spray vaccines
The vaccine may be less effective in protecting against flu, if administered after the amended expiry date
AstraZeneca UK has revised the expiry dates for...
MHRA launches online ‘Eligibility Checker’ tool for marketing authorisation applicants
The tool will facilitate a smooth and efficient application for new medicines via the International Recognition procedure (IRP)
The Medicines and Healthcare products Regulatory...